This report from the Centre for Strategic and International Studies-London School of Hygiene and Tropical Medicine High-Level Panel is the culmination of a year-long consultation with a bipartisan group of global experts. It argues that vaccine confidence is essential to ensuring national security, and recommends bolstering confidence-building efforts in five critical areas.
Related content
![](https://www.vaccineconfidence.org/wp-content/uploads/k1nhgqktso8-aspect-ratio-16-9.jpg)
Working through the spring of 2021, the CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation analysed the diverse forms of vaccine hesitancy in the United States and their links to international phenomena.
![](https://www.vaccineconfidence.org/wp-content/uploads/2022-12-16-134450-aspect-ratio-16-9-1.jpg)
This briefing provides a summary of the report…
![](https://www.vaccineconfidence.org/wp-content/uploads/Screenshot2022-02-09at11.51.53.png)
On Friday 4th February the Center for Strategic and International Studies and the London School of Hygiene and Tropical Medicine’s High-Level Panel on Vaccine Confidence and…
![](https://www.vaccineconfidence.org/wp-content/uploads/pcs3mol14sk-aspect-ratio-16-9.jpg)
In 2018, the European Commission engaged the Vaccine Confidence Project to create the first “State of Vaccine Confidence in the EU” report. Since then, the VCP has conducted bi-annual research to map and monitor public attitudes to vaccines across the region and examine trends over time.
![](https://www.vaccineconfidence.org/wp-content/uploads/fallback-post-thumb.png)
CSIS and the London School of Hygiene and Tropical Medicine’s Vaccine Confidence Project™ have launched a…
![](https://www.vaccineconfidence.org/wp-content/uploads/cityscape-phnom-penh-stockpack-unsplash-scaled-aspect-ratio-16-9-scaled.jpg)
To identify knowledge gaps, beliefs and attitudes in relation to the COVID-19 pandemic and COVID-19 vaccine acceptance among adults in the Asia-Pacific region, the Vaccine Confidence Project conducted two waves of quantitative research in 2021 and 2022.